Delivery Order SPE2DB22D1106-SPE2DB24FFLF6

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lantus 100 unit/ml vials, a brand-name insulin product used for the treatment of diabetes. The contract has a ceiling value of $2,753.96 and an ultimate completion date of July 19, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Lantus 100 unit/mL vial, 10 mL, a prescription insulin medication. The contract has a firm fixed price of $7,641.03 and a completion date of September 10, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated as a set-aside contract. This contract is likely part of a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lantus 100 unit/mL vial 10mL, a diabetes medication. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $2,351.59 and a performance period through May 1, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,022.80 contract is for the provision of Lantus insulin medication (100U/ML, 3ML, 5 syringes) to support federal healthcare programs. The contract has a firm fixed price pricing type and a period of performance through December 20, 2024. Amerisourcebergen holds a larger $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar insulin medication. The contract has a ceiling value of $1,291.10 and a performance period through April 16, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,187.40 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of LANTUS 100 UNIT/ML VIAL 10ML, a prescription insulin medication. The contract has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lantus 100 unit/mL vial, a prescription medication used to treat diabetes. The contract has a ceiling value of $3,875.82 and a completion date of September 15, 2023. It is a firm fixed-price contract, which means the price for the goods is set and not subject to adjustment. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus 100 unit/mL vial 10mL. The $1,468.52 firm fixed-price contract has a performance period through March 17, 2022. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC enables the company to provide a comprehensive range of pharmaceutical...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lantus 100 unit/mL vial, 10mL, a medication used to treat diabetes. The contract has a ceiling value of $1,223.39 and runs through December 18, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin medication. The contract has a ceiling value of $2,375.20 and a completion date of August 7, 2024. This award is a firm fixed price delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFLF6
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of Lantus (insulin glargine) 100 unit/mL vials. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $1,187.40 and a period of performance through September 6, 2024. Amerisourcebergen, a major pharmaceutical distributor, will provide this critical diabetes medication to support military treatment facilities and other federal healthcare programs. The contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a wide range of pharmaceutical and medical commodities.

Generated 12/5/24, 10:12 AM